Ocular Therapeutix (OCUL) Shares Outstanding (2013 - 2026)

Ocular Therapeutix's Shares Outstanding history runs 14 years deep, the most recent figure standing at $218.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 37.44% year-over-year to $218.9 million; the TTM figure through Mar 2026 stood at $218.9 million (up 37.44% YoY), while the FY2025 annual figure was $215.9 million, up 36.88% from the prior year.
• Shares Outstanding was $218.9 million for Q1 2026 at Ocular Therapeutix, up from $215.9 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $218.9 million in Q1 2026 to a low of $76.8 million in Q1 2022.
• Historically, Shares Outstanding has averaged $130.9 million across 5 years, with a median of $154.7 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding rose 0.53% in 2022, then jumped 99.58% in 2024.
• A 5-year view of Shares Outstanding shows it stood at $77.2 million in 2022, then jumped by 48.91% to $115.0 million in 2023, then jumped by 37.22% to $157.7 million in 2024, then surged by 36.88% to $215.9 million in 2025, then rose by 1.38% to $218.9 million in 2026.
• The last three Shares Outstanding figures came in at $218.9 million (Q1 2026), $215.9 million (Q4 2025), and $174.9 million (Q3 2025), per Business Quant data.